Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Protein Complex Assembly

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...

Mechanisms of Membrane-bending

Mechanisms of Membrane-bending

The living membranes are flexible due to their fluid mosaic nature; however, their bending into different shapes is an active process regulated by specific lipids and proteins. The membrane bending can be transient as seen in vesicles or stable for a long time as in microvilli. Cells regulate the size, location, and duration of the membrane curvature.
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...

Export of Misfolded Proteins out of the ER

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...

Mechanisms of Membrane Domain Formation

Mechanisms of Membrane Domain Formation

Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with cytoskeletal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Membrane-Active Peptides Derived from Natural Transmembrane Domains Function as Antibiotic Potentiators.

ACS omega·2025

Same author

Interaction of CFTR Modulators with Mammalian Membrane Mimetics: The Role of Cholesterol.

Biochemistry·2025

Same author

Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screen.

Cell chemical biology·2024

Same author

"Multiplexed screen identifies a <i>Pseudomonas aeruginosa</i> -specific small molecule targeting the outer membrane protein OprH and its interaction with LPS".

bioRxiv : the preprint server for biology·2024

Same author

The Human Mutation K237_V238del in a Putative Lipid Binding Motif within the V-ATPase a2 Isoform Suggests a Molecular Mechanism Underlying Cutis Laxa.

International journal of molecular sciences·2024

Same author

Interaction of designed cationic antimicrobial peptides with the outer membrane of gram-negative bacteria.

Scientific reports·2024

Search research articles

Related Experiment Video

Updated: May 30, 2026

Assays for the Degradation of Misfolded Proteins in Cells

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Membrane protein misassembly in disease.

Derek P Ng¹, Bradley E Poulsen, Charles M Deber

¹Division of Molecular Structure & Function, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

Biochimica Et Biophysica Acta

|August 16, 2011

Summary

This summary is machine-generated.

Missense mutations in transmembrane (TM) domains disrupt α-helical protein folding and assembly, leading to disease. Understanding these molecular mechanisms can guide the development of new therapeutic strategies for protein misassembly disorders.

More Related Videos

Detecting and Characterizing Protein Self-Assembly In Vivo by Flow Cytometry

Detecting and Characterizing Protein Self-Assembly In Vivo by Flow Cytometry

Published on: July 17, 2019

Reconstitution of Msp1 Extraction Activity with Fully Purified Components

Reconstitution of Msp1 Extraction Activity with Fully Purified Components

Published on: August 10, 2021

Related Experiment Videos

Last Updated: May 30, 2026

Assays for the Degradation of Misfolded Proteins in Cells

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Detecting and Characterizing Protein Self-Assembly In Vivo by Flow Cytometry

Detecting and Characterizing Protein Self-Assembly In Vivo by Flow Cytometry

Published on: July 17, 2019

Reconstitution of Msp1 Extraction Activity with Fully Purified Components

Reconstitution of Msp1 Extraction Activity with Fully Purified Components

Published on: August 10, 2021

Area of Science:

Membrane protein biophysics
Molecular genetics
Structural biology

Background:

Integral α-helical membrane proteins rely on helix-helix interactions for proper folding and assembly.
The amino acid sequence of the transmembrane (TM) domain dictates these critical interactions.
Missense mutations affecting TM residues are frequently associated with various diseases.

Purpose of the Study:

To review the molecular mechanisms by which missense mutations cause aberrant folding and assembly of α-helical membrane proteins.
To discuss potential pharmacological strategies for mitigating or reversing the detrimental effects of these mutations.
To highlight the importance of understanding TM helix interactions for therapeutic development.

Main Methods:

Literature review focusing on molecular mechanisms of missense mutations in TM domains.
Analysis of studies linking mutations to protein misfolding and disease.
Exploration of existing and potential pharmacological interventions.

Main Results:

Missense mutations can lead to altered TM helix packing, affecting protein stability and function.
Aberrant folding and assembly are common consequences of mutations in critical TM residues.
Pharmacological approaches show promise in correcting or compensating for mutation-induced defects.

Conclusions:

Understanding the impact of missense mutations on TM helix interactions is crucial for disease insight.
Targeting these interactions offers a pathway for developing novel therapeutics against protein misassembly diseases.
Further research into molecular mechanisms will enhance the development of effective treatments.